In last year’s Academy Award-nominated film “Bridge of Spies,” Tom Hanks plays a lawyer who defends an accused Soviet spy in the U.S. The Hanks character appears to be dumbfounded that he has been asked to take on such an assignment. “I’m an insurance lawyer,” he says. The real lawyer whom Hanks portrays, James B. Donovan ’40, was that—and much more.
When Wendy Sherman, former under secretary of state for political affairs, was in the midst of negotiations over Iran’s nuclear program, she often felt that her team was playing “several games of multidimensional chess at the same time.” On April 20, Sherman delivered a guest lecture to the Harvard Law School Negotiation Workshop.
“FDA in the 21st Century: The Challenges of Regulating Drugs and New Technologies,” edited by Holly Fernandez Lynch and I. Glenn Cohen ’03 (Columbia). Stemming from a 2013 conference at HLS, the book features essays covering major developments that have changed how the FDA regulates; how the agency encourages transparency; First Amendment issues; access to drugs; and evolving issues in drug-safety communication. These issues, the editors write, lie “at the heart of our health and health care.”
Harvard Law School students Phil Caruso ’18 and Pamela Nwaoko ’16 are among 12 law students selected by FASPE (Fellowships at Auschwitz for the Study of Professional Ethics) to participate in a two-week program in Europe this summer, which uses the conduct of lawyers and judges in Nazi Germany as a launching point for an intensive course of study on ethics in the legal profession today.